These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8266959)

  • 1. Multidisciplinary task force for controlling drug expenses.
    Hayman JN; Crane VS
    Am J Hosp Pharm; 1993 Nov; 50(11):2343-7. PubMed ID: 8266959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost containment through P & T committee drug utilization review.
    Bender FH; DeMatteo CS
    Hosp Formul; 1984 Aug; 19(8):699-700, 705-7. PubMed ID: 10267391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy management strategies for responding to hospital reimbursement changes.
    Curtiss FR
    Am J Hosp Pharm; 1983 Sep; 40(9):1489-92. PubMed ID: 6353913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monetary incentive for pharmacists to control drug costs.
    Herrick JD; Manning SH
    Am J Hosp Pharm; 1985 Jul; 42(7):1527-32. PubMed ID: 4025348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria-based antimicrobial i.v. to oral conversion program.
    Okpara AU; Maswoswe JJ; Stewart K
    Formulary; 1995 Jun; 30(6):343-8. PubMed ID: 10144873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of clinical and administrative strategies to reduce expenditures for antimicrobial agents.
    Hess DA; Mahoney CD; Johnson PN; Corrao WM; Fisher AE
    Am J Hosp Pharm; 1990 Mar; 47(3):585-91. PubMed ID: 2316543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a service improvement program for ambulatory pharmacy services.
    Hayman JN; Hatwig CA; Crane VS
    Pharm Pract Manag Q; 1996 Oct; 16(3):67-78. PubMed ID: 10166237
    [No Abstract]   [Full Text] [Related]  

  • 10. Antimicrobial formulary management: a case study in a teaching hospital.
    Wright DB
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):27S-31S. PubMed ID: 2011570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors that influence prescribing decisions.
    Schumock GT; Walton SM; Park HY; Nutescu EA; Blackburn JC; Finley JM; Lewis RK
    Ann Pharmacother; 2004 Apr; 38(4):557-62. PubMed ID: 14966259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulary management to reduce cost: P & T committee strategies.
    Roberts MJ; Summerfield MR
    Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reimbursement and costs of pediatric ambulatory diabetes care by using the resource-based relative value scale: is multidisciplinary care financially viable?
    Melzer SM; Richards GE; Covington ML
    Pediatr Diabetes; 2004 Sep; 5(3):133-42. PubMed ID: 15450008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of a P & T Committee in a community teaching hospital.
    Cooke DH; Kessler J
    Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
    Godman B; Wettermark B; Hoffmann M; Andersson K; Haycox A; Gustafsson LL
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):65-83. PubMed ID: 19371180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a two-stage intervention program on cefazolin usage at a major teaching hospital.
    Gupta S; Bachand RL; Jewesson PJ
    Hosp Formul; 1989 Jan; 24(1):41-4, 46. PubMed ID: 10291599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving materials management through re-engineering.
    Born CM; Marino D
    Healthc Financ Manage; 1995 Sep; 49(9):30-4, 36, 38. PubMed ID: 10145093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulary management at a tertiary-care facility: P&T committee interview.
    Lucas RV; Abramowitz PW
    Hosp Formul; 1988 Feb; 23(2):162-8, 172-3. PubMed ID: 10286021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a pharmacy-based cost-containment program on cimetidine costs and use.
    Kong KM; Johnson WF; Anderson PO; Sato LA; Simonian RI
    Am J Hosp Pharm; 1987 Sep; 44(9):2068-73. PubMed ID: 3674045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.